What is Roivant Sciences's total equity?

Roivant Sciences (ROIV) reported total equity of $4.53B in Q1 2026.

How has Roivant Sciences's total equity changed year-over-year?

Roivant Sciences's total equity decreased by 3.4% year-over-year, from $4.69B to $4.53B.

What is the long-term trend for Roivant Sciences's total equity?

Over 5 years (2020 to 2025), Roivant Sciences's total equity has grown at a 20.3% compound annual growth rate (CAGR), from $1.8B to $4.53B.

What does total equity mean?

Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Roivant Sciences ROIV Total Equity

Total Equity at other companies

AmgenAMGN

$9.19B+48.1%

ModernaMRNA

$7.41B-26.4%

Immunovant, Inc.IMVT

$852.59M+20.5%

Bristol-Myers SquibbBMY

$20.07B+15.4%

AbbVieABBV

-$6.66B-569%

RegenxbioRGNX

$21.08M-92.3%

Other financials

Income statement

See full

Revenue$2.5M-66.7%

Operating income-$339.2M-23.6%

Net income-$265.9M-257%

EPS (diluted)-$0.38-265%

Balance sheet

See full

Cash & equivalents$1.4B+1,411%

Total debt$107.4M+7.3%

Total assets$5.7B+5.0%

Cash flow

See full

Operating cash flow-$163.8M+5.1%

CapEx$1.3M+55.5%

Free cash flow-$165.1M+4.8%

Valuation

See full

Market cap$25.45B+220%

Enterprise value$24.14B+204%

P/S3,081.7×+2,740×

Profitability

See full

Operating margin-9,130.5%-13,995pp

Net margin-6,079.9%-6,193pp

FCF margin-9,183.5%-17,093pp

Returns & leverage

See full

Return on equity-17.1%-17.7pp

Debt / equity0×0.0×

Current ratio18.4×-15.1×

Where this comes from

Reported directly by Roivant Sciences in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Roivant Sciences’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Roivant Sciences's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Roivant Sciences's total equity?: Roivant Sciences (ROIV) reported total equity of $4.53B in Q1 2026.
How has Roivant Sciences's total equity changed year-over-year?: Roivant Sciences's total equity decreased by 3.4% year-over-year, from $4.69B to $4.53B.
What is the long-term trend for Roivant Sciences's total equity?: Over 5 years (2020 to 2025), Roivant Sciences's total equity has grown at a 20.3% compound annual growth rate (CAGR), from $1.8B to $4.53B.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.